This summer, FloraWorks kicked off a 1500-person placebo blinded sleep study to evaluate the effectiveness of CBN for treating sleep disorders when administered in three dosages. This study will allow us to evaluate the impact of FloraWorks manufactured TruCBN™ on the quality and duration of sleep when taken consistently each night.

FloraWorks looks forward to the potential of offering our clients the supporting research to make claims for the treatment of sleep disorders for their products containing TruCBN™.